Holen Sie sich die Stockscreener-App
39.52
0.10%
0.04
Handel nachbörslich:
39.52
Schlusskurs vom Vortag:
$39.48
Offen:
$39.54
24-Stunden-Volumen:
95,621
Relative Volume:
0.35
Marktkapitalisierung:
$1.60B
Einnahmen:
$982.01M
Nettoeinkommen (Verlust:
$14.80M
KGV:
106.81
EPS:
0.37
Netto-Cashflow:
$37.02M
1W Leistung:
-3.80%
1M Leistung:
+3.54%
6M Leistung:
+35.44%
1J Leistung:
+77.30%
1-Tages-Spanne:
$39.28
$39.91
1-Wochen-Bereich:
$38.29
$42.82
52-Wochen-Spanne:
$16.16
$46.42
Phibro Animal Health Corp Stock (PAHC) Company Profile
Firmenname
Phibro Animal Health Corp
Sektor
Telefon
201-329-7300
Adresse
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Vergleichen Sie PAHC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
39.52 | 1.60B | 982.01M | 14.80M | 37.02M | 0.37 |
|
ZTS
Zoetis Inc
|
124.96 | 54.61B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.91 | 52.47B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.42 | 46.18B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.53 | 36.87B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
476.78 | 20.38B | 3.08B | 1.24B | 1.07B | 25.61 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-06-16 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2024-09-10 | Eingeleitet | JP Morgan | Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2022-12-21 | Eingeleitet | ROTH Capital | Buy |
| 2022-07-25 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-07-07 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-08-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2020-01-28 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-09-05 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | Bestätigt | BofA/Merrill | Underperform |
| 2019-06-11 | Eingeleitet | Barclays | Underweight |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-05-09 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2017-08-23 | Fortgesetzt | BofA/Merrill | Underperform |
| 2017-06-02 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-11-11 | Herabstufung | Macquarie | Neutral → Underperform |
| 2016-11-10 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2016-04-11 | Bestätigt | Guggenheim | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2016-01-15 | Herabstufung | Barclays | Overweight → Underweight |
| 2015-09-30 | Eingeleitet | Gabelli & Co | Buy |
| 2015-04-24 | Bestätigt | Barclays | Overweight |
| 2015-04-21 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | Eingeleitet | Barclays | Overweight |
Alle ansehen
Phibro Animal Health Corp Aktie (PAHC) Neueste Nachrichten
What makes Prothena Corporation plc stock price move sharply - baoquankhu1.vn
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now? - Yahoo Finance
Lobbying Update: $30,000 of PHIBRO ANIMAL HEALTH CORPORATION lobbying was just disclosed - Quiver Quantitative
Phibro Animal Health (NASDAQ:PAHC) Shares Down 5% Following Insider Selling - MarketBeat
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term - Yahoo Finance
Phibro Animal Health (PAHC) director sells $1.16 million in stock By Investing.com - Investing.com UK
Phibro Animal Health (PAHC) director sells $1.16 million in stock - Investing.com
Why The Narrative Around Phibro Animal Health (PAHC) Is Shifting With The New Price Target - Yahoo Finance
Campbell & CO Investment Adviser LLC Sells 28,942 Shares of Phibro Animal Health Corporation $PAHC - Defense World
Phibro Animal Health (PAHC) director sells $569k in shares - Investing.com
Phibro Animal Health (PAHC) director sells $569k in shares By Investing.com - Investing.com South Africa
Reasons to Add Fresenius Medical Stock to Your Portfolio Now - Finviz
Phibro Animal Health Stock Climbs 90.9% in a Year: What's Driving It? - Yahoo Finance
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now - Finviz
Phibro (PAHC) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Here's Why Phibro Animal Health (PAHC) is a Strong Growth Stock - Yahoo Finance
BFI Co sells Phibro Animal Health (PAHC) shares for $8554 By Investing.com - Investing.com South Africa
Glycolic Acid Market is expected to generate a revenue of USD 461.74 Million by 2032, Globally, at 5.73% CAGR: Verified Market Research® - GlobeNewswire Inc.
BFI Co sells Phibro Animal Health (PAHC) shares for $8554 - Investing.com
Assessing Phibro Animal Health (PAHC) Valuation After Recent Share Price Strength - Yahoo Finance
Is Phibro Animal Health (PAHC) Pricing Reflecting Its Strong Multi Year Share Price Performance? - Yahoo Finance
3 Reasons Why Growth Investors Shouldn't Overlook Phibro (PAHC) - Yahoo Finance
Zacks Research Issues Optimistic Outlook for PAHC Earnings - Defense World
BFI Co sells Phibro Animal Health (PAHC) shares worth $13,148 By Investing.com - Investing.com Australia
BFI Co sells Phibro Animal Health (PAHC) shares worth $13,148 - Investing.com
Is Phibro Animal Health (PAHC) a Great Value Stock Right Now? - Yahoo Finance
Can Phibro Animal Health Corporation stock deliver consistent earnings growthFibonacci Extensions & Free Daily Stock Hotspot Analysis - ulpravda.ru
Phibro Animal Health Corporation (NASDAQ:PAHC) Receives Average Rating of “Hold” from Analysts - Defense World
Phibro Animal Health (NASDAQ:PAHC) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings - Yahoo Finance
Trend Dashboard Flags Symbiox Investment Trading Co Ltd As Potential Swing TradeDividend Stability Analysis & Free Explosive Earning Power - earlytimes.in
Phibro Animal Health Corporation (NASDAQ:PAHC) Receives Average Rating of "Hold" from Analysts - MarketBeat
Here's Why You Should Retain Glaukos Stock in Your Portfolio Now - Finviz
Reasons to Retain Baxter International Stock in Your Portfolio Now - Finviz
Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
Phibro Animal Health (STU:PB8) EV-to-OCF : 27.56 (As of Dec. 23, 2025) - GuruFocus
Phibro Animal Health names Bendheim new president and CEO - roi-nj.com
Phibro Animal Health (PAHC): Assessing Valuation After a Recent Pullback and Strong Year-to-Date Rally - simplywall.st
Published on: 2025-12-21 06:36:24 - Улправда
Is Phibro Animal Health Corporation stock resilient to inflation2025 Valuation Update & Daily Profit Maximizing Trade Tips - Улправда
Phibro Animal Health (PAHC): Rethinking Valuation After a 95% Year-to-Date Surge and Recent Pullback - Yahoo Finance
Phibro Animal Health says Daniel Bendheim to assume CEO role in July - MSN
Phibro Animal Health (NASDAQ:PAHC) Shares Gap DownHere's What Happened - MarketBeat
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock - Yahoo Finance
Why hedge funds are buying Phibro Animal Health Corporation stockWeekly Gains Report & Risk Managed Investment Strategies - DonanımHaber
Is Phibro Animal Health Corporation stock a defensive play in 20252025 Breakouts & Breakdowns & Risk Adjusted Buy/Sell Alerts - DonanımHaber
Is Phibro Animal Health Corporation stock supported by strong fundamentalsTrade Volume Summary & AI Forecast Swing Trade Picks - Улправда
Phibro Animal Health Corp. Announces Leadership Transition - citybiz
Leadership Changes at Phibro Animal Health (PAHC) Aim to Drive F - GuruFocus
Phibro Animal Health announces leadership transition - Feedstuffs
Phibro Animal Health announces CEO transition effective July 2026 - Investing.com
Phibro Animal Health Names Dani Bendheim as CEO, Jack Bendheim Becomes Executive Chairman - marketscreener.com
Finanzdaten der Phibro Animal Health Corp-Aktie (PAHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
9.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):